Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
For business development teams evaluating M&A or in-licensing targets, patent estate quality assessment is a prerequisite for deal valuation
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment (ATTAIN-1) , New England Journal of Medicine, 2025 [Accessed 25 June 2026]
Small molecule GLP-1 agonists and antagonists (such as those in development at Structure Therapeutics) may facilitate study of endogenous GLPs activity and increase clinical uptake in T2D and obesity patients
Our GLP-1 programs include: Weekly Semaglutide or Tirzepatide dosing MIC+B12 add-ons for metabolic boost NAD+ and Glutathione support to match your energy and detox needs Education on what to eat and when to supplement See our affordable medical weight loss plans What About Other Add-Ons Like Sermorelin or Tirzepatide
US$ 21.89
US$ 25.24
US$ 20.05
US$ 22.44
US$ 23.19
